Cytogel Pharma Stock
Cytogel Pharma is a clinical-stage biopharmaceutical company focused on developing novel, non-addictive pain management therapies. Its lead candidate, CYT-1010, is a first-in-class endomorphin-based analgesic designed to provide effective pain relief while minimizing the risks associated with traditional opioids.
Founded: 2006
For more Cytogel Pharma stock information, or to buy or sell private shares, sign up for a MicroVentures account.
Management Team
| Dean Maglaris Chief Executive Officer |
| Theodore Maione Chief Scientific Officer |
